Additionally, the inhibition of c-Met activity impairs the survival, invasion and tube formation of HUVECs in vitro and reduces neovascularization and the formation of micro vessels in tumor models (20, 21).Thus, inhibiting c-Met-induced angiogenesis will be an potential approach to treat glioblastoma. The gene discussed is MET; the disease is glioblastoma.